Related Experiment Videos
Propensity score analysis evaluating preoperative glucocorticoid administration in elective colectomy
Daniel Lemanu1, Sanket Srinivasa, Primal Singh
1Department of Surgery, South Auckland Clinical School, University of Auckland, New Zealand. Daniel.Lemanu@middlemore.co.nz
International Journal of Surgery (London, England)
|October 31, 2012
Summary
Preoperative glucocorticoid (GC) administration in elective colectomy patients significantly reduced hospital stay length. This study found no increase in postoperative complications, suggesting GC use is beneficial for surgical recovery.
Area of Science:
- Surgical outcomes research
- Pharmacological interventions in surgery
- Enhanced Recovery After Surgery (ERAS) protocols
Background:
- Preoperative glucocorticoid (GC) administration can mitigate surgical stress and improve outcomes.
- GC use is not yet standard practice for all surgical procedures.
- Evaluating GC's role in elective colectomy is crucial for optimizing patient care.
Purpose of the Study:
- To assess the impact of preoperative glucocorticoid (GC) administration on clinical outcomes in patients undergoing elective colectomy.
- To determine if GC use influences complication rates and length of hospital stay (LOS).
- To analyze the association between GC administration and patient recovery within an ERAS program.
Main Methods:
- Retrospective analysis of prospectively collected data from elective colectomy patients (2006-2010) within an ERAS program.
- Investigated demographic data, surgery type, GC administration, complication rates, and LOS.
- Employed univariate and propensity score analyses to evaluate outcomes, with statistical significance set at p ≤ 0.05.
Main Results:
- 146 of 253 patients received preoperative GC, with baseline differences noted in gender and ASA classification.
- Univariate analysis showed no significant differences in total complications, major complications, anastomotic leaks, or infectious complications between groups.
- Propensity score analysis revealed that preoperative GC administration was independently associated with a reduced LOS (5 days vs. 6 days, p = 0.04).
Conclusions:
- Preoperative glucocorticoid administration is linked to a shorter hospital stay for elective colectomy patients.
- GC use did not result in an increased incidence of postoperative complications.
- Findings support the consideration of preoperative GC administration within ERAS protocols to enhance surgical recovery.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...